Systematic profiling of immune signatures identifies prognostic predictors in lung adenocarcinoma.
Mao S, Li Y, Lu Z, Che Y, Huang J, Lei Y, Wang Y, Wang X, Liu C, Zheng S, Li N, Li J, Sun N, He J.
Mao S, et al. Among authors: lu z.
Cell Oncol (Dordr). 2020 Aug;43(4):681-694. doi: 10.1007/s13402-020-00515-7. Epub 2020 May 28.
Cell Oncol (Dordr). 2020.
PMID: 32462608